U.S. FDA issues observation to Aurobindo Pharma arm’s API unit
U.S. FDA headquarters in White Oak, Maryland | Photo Credit: Reuters An active pharmaceutical ingredient (API) manufacturing facility of Aurobindo Pharma subsidiary Apitoria Pharma near Hyderabad has been issued an observation by the U.S. Food and Drug Administration (U.S. FDA). Apitoria Pharma’s Unit-II, an API manufacturing facility, in Sangareddy district, was inspected from September 7-15….
Read More “U.S. FDA issues observation to Aurobindo Pharma arm’s API unit” »